Edition:
United States

Clinuvel Pharmaceuticals Ltd (CLVLY.PK)

CLVLY.PK on OTC Markets Group

5.39USD
28 Mar 2017
Change (% chg)

$0.14 (+2.67%)
Prev Close
$5.25
Open
$5.30
Day's High
$5.39
Day's Low
$5.30
Volume
840
Avg. Vol
6,641
52-wk High
$6.92
52-wk Low
$3.00

Latest Key Developments (Source: Significant Developments)

Clinuvel Pharmaceuticals agrees with FDA on new drug application timelines
Wednesday, 9 Nov 2016 01:51am EST 

Clinuvel Pharmaceuticals Ltd :clinuvel agrees with FDA on new drug application timelines-.  Full Article

Clinuvel Pharmaceuticals agrees with FDA on new drug application timelines
Tuesday, 8 Nov 2016 05:45pm EST 

Clinuvel Pharmaceuticals Ltd :clinuvel agrees with FDA on new drug application timelines-.  Full Article

Clinuvel Pharmaceuticals says FDA accepts Scenesse clinical data package for NDA submission
Sunday, 17 Jul 2016 08:04pm EDT 

Clinuvel Pharmaceuticals Ltd : FDA accepts scenesse® clinical data package for nda submission . Says FDA has deemed clinuvel's clinical data package satisfactory for submitting a new drug application .  Full Article

Clinuvel Pharmaceuticals says FDA awards EPP treatment drug fast track designation
Tuesday, 5 Jul 2016 06:26pm EDT 

Clinuvel Pharmaceuticals Ltd : FDA awards SCENESSE fast track designation for EPP treatment .  Full Article

Clinuvel Pharmaceuticals announces inclusion of its ADR program in NASDAQ's international designation
Wednesday, 1 Jun 2016 06:24pm EDT 

Clinuvel Pharmaceuticals Ltd : Announced the inclusion of its sponsored level 1 American depository receipt (adr) program in NASDAQ's international designation .  Full Article

More From Around the Web

BRIEF-Clinuvel Pharmaceuticals agrees with FDA on new drug application timelines

* clinuvel agrees with FDA on new drug application timelines- Source text for Eikon: Further company coverage:

No consensus analysis data available.